Dr. Curtis Lockshin
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. Curtis Lockshin
Xenetic Biosciences, Inc. reported in an 8-K filed May 22, 2024 that Dr. Curtis Lockshin resigned as Chief Scientific Officer, effective May 16, 2024. The proxy statement of Xenetic Biosciences, Inc. reports total compensation of $554,083 for Dr. Curtis Lockshin in fiscal 2024, including a base salary of $166,992. Disclosed compensation is on record for 7 fiscal years.
“In addition on May 16, 2024, the Company and Dr. Curtis Lockshin mutually agreed that Dr. Lockshin would step down as the Chief Scientific Officer of the Company, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Xenetic Biosciences, Inc. (XBIO)
Proxy statement
Start not stated–2024-05-16
-
Xenetic Biosciences, Inc. (XBIO)
Proxy statement
Start not stated–2024-05-16
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Xenetic Biosciences, Inc. (XBIO) | Former Chief Scientific Officer | $166,992 | $554,083 |
| 2023 | Xenetic Biosciences, Inc. (XBIO) | Former Chief Scientific Officer | $329,175 | $435,816 |
| 2022 | Xenetic Biosciences, Inc. (XBIO) | Former Chief Scientific Officer | $329,175 | $470,371 |
| 2021 | Xenetic Biosciences, Inc. (XBIO) | Chief Scientific Officer | $299,250 | $508,320 |
| 2020 | Xenetic Biosciences, Inc. (XBIO) | Chief Scientific Officer | $285,000 | $347,203 |
| 2019 | Xenetic Biosciences, Inc. (XBIO) | Chief Scientific Officer | $250,000 | $383,793 |
| 2018 | Xenetic Biosciences, Inc. (XBIO) | Chief Scientific Officer | $250,000 | $259,584 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.